What is new from the Canadian Paediatric Society Committee on Infectious Diseases and Immunization?

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 25, Issue 3, 2014, Pages 130-132

  Robinson, Joan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; MENINGOCOCCUS VACCINE; VANCOMYCIN;

ARTICLE; BACTERIAL MENINGITIS; CANADA; CESAREAN SECTION; CLOSTRIDIUM DIFFICILE; EPIDEMIC MENINGITIS; HERPES SIMPLEX; IMMUNIZATION; INFECTION; MEDICAL SOCIETY; MENINGOCOCCOSIS; ORGAN TRANSPLANTATION; PEDIATRICS; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE;

EID: 84903642047     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2014/861346     Document Type: Article

References (21)

1. Allen UD, Robinson JL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Prevention and management of neonatal herpes simplex virus infections. Paediatr Child Health 2014;19;201-6.
2. Randolph AG, Washington AE, Prober CG. Cesarian delivery for women presenting with genital herpes lesions: Efficacy, risks, and costs. JAMA 1993;270:77-82. (Pubitemid 23202656)
3. Pinninti SG, Angara R, Feja KN, et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: A multicenter case series. J Pediatr 2012;161:134-8.e1-3.
4. Tronstein E, Johnston C, Huang ML, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011;305:1441-9.
5. Howard M, Sellors JW, Jang D, et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003;41:84-9. (Pubitemid 36098558)
6. Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transmit Dis 2001;28:424-8. (Pubitemid 32613687)
7. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: Results of a 3-year national prospective study. Pediatrics 2006;117:1955-62. (Pubitemid 46071239)
8. Gilbert M, Li X, Petric M et al. Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health 2011;102;225-9.
9. Tuite AR, McCabe CJ, Ku J, Fisman DN. Projected cost-saving with herpes simplex virus screening in pregnancy: Towards a new screening paradigm. Sex Transm Infect 2011;87:141-8.
10. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9. (Pubitemid 36068708)
11. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transmit Dis 2003;30:310-4. (Pubitemid 36397831)
12. Vanderpluym C, Tawfik G, Hervas-Malo M, Lacaze-Masmonteil T, Kellner J, Robinson JL. Empiric acyclovir for neonatal herpes simplex virus infection. J Matern Fetal Neonatal Med 2012;25:278-82.
13. Le Saux N; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age. Paediatr Child Health 2014;19:141-6.
14. Allen UD; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Clostridium difficile in paediatric populations. Paediatr Child Health 2014;19:43-8.
15. Schwartz KL, Darwish I, Richardson SE, Mulvey MR, Thampi N. Severe clinical outcome is uncommon in Clostridium difficile infection in children: A retrospective cohort study. BMC Pediatrics 2014;14:28.
16. Robinson JL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Immunization for meningococcal serogroup B - What does the practitioner need to know? Paediatr Child Health 2014;19:91-4.
17. NACI statement on meningococcal B vaccine which is not yet on-line but hopefully will be by the time this article comes out
18. Bettinger JA, Scheifele DW, Halperin SA, et al; members of the Canadian Immunization Monitoring Program, Active (IMPACT). Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).Vaccine 2013;32:124-30.
19. Santé et services social Québec. Vaccination: The best protection! 〈www.msss.gouv.qc.ca/sujets/santepub/vaccination/index.php? accueil-en〉 (Accessed April 24, 2014).
20. Allen UD; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Minimizing infection risks after paediatric organ transplants: Advice for practitioners. Paediatr Child Health 2013;18:143-8.
21. MacDonald NE, Finlay JC; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Working with vaccine-hesitant parents. Paediatr Child Health 2013;18:265-7.